ELISA based Diagnosis of Neurodegeneration
These easy-to-handle and ultrasensitive immunoassays provide improved diagnosis for Alzheimer’s, Parkinson’s, and Creutzfeldt-Jakob disease. They use recombinant proteins and rapidly generating monoclonal antibodies unique to a variety of biomarkers.
Alzheimer’s Disease
The most common form of dementia, Alzheimer’s disease (AD) is a progressive neurodegenerative disorder. AD affects more than 36 million people worldwide and occurs most commonly in Western Europe. Our solutions:
Parkinson’s Disease
The hallmark of Parkinson’s disease is the presence of Lewy bodies in subcortical brain regions. Lewy bodies are deposits made of aggregated and phosphorylated α-synuclein. Our solutions:
Creutzfeldt-Jakob Disease
The third area in this profile focuses on differential diagnostics for rapid-onset Creutzfeldt-Jakob disease (CJD). This disease is caused by the aggregation of cellular prion protein. Human prion disorders are rare and only affect one to two cases per million people.
Our solutions:
Manufacturer Analytik Jena GmbH+Co. KG
Be the first to review this product